Biogen
BIIB
BIIB
1,024 hedge funds and large institutions have $53.8B invested in Biogen in 2016 Q4 according to their latest regulatory filings, with 137 funds opening new positions, 364 increasing their positions, 400 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,024
Holders Change
+13
Holders Change %
+1.29%
% of All Funds
25.64%
Holding in Top 10
41
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-28.07%
% of All Funds
1.03%
New
137
Increased
364
Reduced
400
Closed
107
Calls
$1.52B
Puts
$1.74B
Net Calls
-$222M
Net Calls Change
-$123M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$371M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$314M |
| 3 |
Two Sigma Investments
New York
|
+$152M |
| 4 |
Renaissance Technologies
New York
|
+$133M |
| 5 |
Two Sigma Advisers
New York
|
+$126M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$701M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$430M |
| 3 |
SIG
Senator Investment Group
New York
|
-$142M |
| 4 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$142M |
| 5 |
HM
HealthCor Management
New York
|
-$117M |
